Assignee
ROSEMONT PHARMACEUTICALS LTD
GB·9 granted patents·2 pending applications·41 citations·filing 2013–2024
Top patents by PatentIndex Score
11 records- 0194US11116724B2Methotrexate compositionROSEMONT PHARMACEUTICALS LTD·Filed 2020·Granted Sep 14, 2021·3 cites·30 claims
- 0294US9259427B2Methotrexate compositionROSEMONT PHARMACEUTICALS LTD·Filed 2013·Granted Feb 16, 2016·24 cites·13 claims
- 0391US10610485B2Methotrexate compositionROSEMONT PHARMACEUTICALS LTD·Filed 2019·Granted Apr 7, 2020·3 cites·13 claims
- 0489US10231927B2Methotrexate compositionROSEMONT PHARMACEUTICALS LTD·Filed 2017·Granted Mar 19, 2019·5 cites·24 claims
- 0589US9855215B2Methotrexate compositionROSEMONT PHARMACEUTICALS LTD·Filed 2016·Granted Jan 2, 2018·6 cites·12 claims
- 0689US2025041216A1Methotrexate CompositionROSEMONT PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 0785US12396947B2Methotrexate compositionROSEMONT PHARMACEUTICALS LTD·Filed 2023·Granted Aug 26, 2025·0 cites·1 claims
- 0879US11969503B2Methotrexate compositionROSEMONT PHARMACEUTICALS LTD·Filed 2021·Granted Apr 30, 2024·0 cites·20 claims
- 0944US12419857B2Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailabilityROSEMONT PHARMACEUTICALS LTD·Filed 2018·Granted Sep 23, 2025·0 cites·5 claims
- 1037US10300041B2Liquid oral simvastatin compositionsROSEMONT PHARMACEUTICALS LTD·Filed 2017·Granted May 28, 2019·0 cites·20 claims
- 1135US2019209526A1Stable Atorvastatin Suspension CompositionROSEMONT PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ROSEMONT PHARMACEUTICALS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →